Literature DB >> 7524882

Central role of CD40 and its ligand in B lymphocyte responses to T-dependent antigens.

J Gordon1, A Katira, M Holder, I MacDonald, J Pound.   

Abstract

In order to mount an effective antibody response to soluble and certain other types of antigens, B cells need help from T cells. Recently, an important receptor-ligand pair has been identified as essential for successful cognate interaction between these two classes of lymphocytes. CD40 was first identified as a receptor-like molecule on B cells which when ligated by antibody could deliver signals to prime for growth, differentiation, or survival. Later its counterstructure--termed CD40 ligand (CD40L)--was discovered to be an inducible type II glycoprotein of helper T cells. In this review, the central role of the CD40-CD40L interaction in the various phases of the B cell response to T-dependent antigens is discussed drawing from both in vitro and in vivo studies.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7524882

Source DB:  PubMed          Journal:  Cell Mol Biol (Noisy-le-grand)        ISSN: 0145-5680            Impact factor:   1.770


  4 in total

Review 1.  Fortifying B cells with CD154: an engaging tale of many hues.

Authors:  J Gordon; J D Pound
Journal:  Immunology       Date:  2000-07       Impact factor: 7.397

2.  Production of immunoglobulins by human sIgD+ and sIgD- human blood B lymphocytes in response to stimulation with activated T cells and agonistic antibodies; effect of IL-10, IL-2 and mode of activation of T cells.

Authors:  N R Ling; B Brown; D Hardie
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

Review 3.  Programmed cell death: the influence of CD40, CD95 (Fas or Apo-I) and their ligands.

Authors:  N Laytragoon-Lewin
Journal:  Med Oncol       Date:  1998-04       Impact factor: 3.064

Review 4.  Regulation of germinal center B-cell differentiation.

Authors:  Yang Zhang; Laura Garcia-Ibanez; Kai-Michael Toellner
Journal:  Immunol Rev       Date:  2016-03       Impact factor: 12.988

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.